DevaTal Inc

http://www.devatal.com

DevaTal manufactures biological products for basic research, clinical research, and clinical diagnostic markets. DevaTal's biological reagents are used in life science research, and for immunological detection of infectious diseases and other analytes. We produce recombinant proteins, monoclonal antibodies, and other research reagents. DevaTal Inc. was established in 2003 to exploit proprietary technologies for the production of recombinant proteins and monoclonal antibodies. The company utilizes colloidal gold and fluorescence detection techniques to develop rapid diagnostic tests for infectious diseases and other analytes. DevaTal focuses its expertise and technology in the following areas: The development and marketing of superior recombinant proteins corresponding to HIV, HTLV, hepatitis, and other related proteins. The development and marketing of reagents for rapid and simple diagnostic tests. The development of monoclonal antibodies (mAbs) and other immuno-reagents required for Research and Diagnostic purposes. DevaTal uses both direct and indirect sales through strategic alliances in various market segments. The company has R&D contracts with key diagnostic corporations in both the USA and offshore. We provide the technology and know-how for the production of large-scale rapid detection tests for HIV, hepatitis, and other associated proteins. These relationships are based on OEM, royalties, and profit sharing agreements.

• 12/8/2013
• 5
• 0